Keio University

Press Release

871-880 items (total 1561)
Published At May 28, 2021

KGRI Launches "2040 Independence and Self-Respect Project": Aiming to Establish Global Standards for a Sustainable Super-Aging Society

Published At May 28, 2021

"Keio Object Hub," a Portal Site for Keio University's Cultural Collections, Begins Collaboration with "Japan Search"

Published At May 28, 2021

Discovery of a New Candidate Factor Associated with the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)—Toward Elucidating the Mechanism of Selective Motor Neuron Degeneration Using Patient-Derived iPS Cells—

Published At May 28, 2021

A Global Atlas of Urban Microbes and Antimicrobial Resistance Genes—Metagenomic Analysis of Approximately 5,000 Samples Collected from 60 Cities Worldwide

Published At May 27, 2021

Establishment of a Large-Scale Genome Cohort of 366,000 People: Six Domestic Research Institutions Collaborate for the Early Realization of Personalized Medicine and Personalized Prevention—Mutual Utilization of Data to Contribute to the Early Realization of Next-Generation Medicine

Published At May 26, 2021

A Joint Paper on Prediction of Optical Properties of OLED Materials was Published in a Nature Research Journal -The World-First Calculation of the Excited States of OLED Materials on Quantum Computers-

Published At May 26, 2021

New Industry-Academia-Government Collaboration Project Launched to Connect Municipalities and Companies Through the 17 SDGs, Aiming to Solve Issues and Promote Regional Co-creation

Published At May 26, 2021

Research Results on Predicting the Performance of OLED Light-Emitting Materials Published in a Nature Journal—World's First Successful Calculation of the Excited State of OLED Light-Emitting Materials Using a Real Quantum Computer

Published At May 25, 2021

Understanding How Violet Light Can Stop Myopia Progression

Published At May 25, 2021

Violet Light Suppresses Myopia Progression via the Non-visual Photoreceptor OPN5—Elucidating the Function of the Photoreceptive Protein OPN5 and Its Potential as a Therapeutic Target for Myopia